Encompass Health Corp (NYSE:EHC) has been given a consensus broker rating score of 1.90 (Buy) from the ten analysts that cover the company, Zacks Investment Research reports. Four investment analysts have rated the stock with a hold rating, one has given a buy rating and five have issued a strong buy rating on the company. Encompass Health’s rating score has improved by 0.5% in the last 90 days as a result of a number of analysts’ ratings changes.
Brokerages have set a 12 month consensus price target of $57.20 for the company and are predicting that the company will post $0.81 EPS for the current quarter, according to Zacks. Zacks has also given Encompass Health an industry rank of 79 out of 265 based on the ratings given to related companies.
A number of equities analysts recently commented on EHC shares. Bank of America raised Encompass Health from an “underperform” rating to a “neutral” rating in a report on Thursday, January 4th. ValuEngine raised Encompass Health from a “hold” rating to a “buy” rating in a report on Monday, February 5th. Credit Suisse Group reissued an “outperform” rating on shares of Encompass Health in a report on Tuesday, February 27th. Craig Hallum reissued a “buy” rating and set a $60.00 price target (up from $54.00) on shares of Encompass Health in a report on Tuesday, January 9th. Finally, Piper Jaffray Companies reissued a “hold” rating on shares of Encompass Health in a report on Thursday, March 1st.
Encompass Health (NYSE EHC) traded down $0.01 on Tuesday, hitting $58.03. The stock had a trading volume of 316,770 shares, compared to its average volume of 590,712. Encompass Health has a 1 year low of $40.86 and a 1 year high of $59.29. The company has a debt-to-equity ratio of 1.79, a current ratio of 1.36 and a quick ratio of 1.36. The stock has a market cap of $5,702.87, a PE ratio of 20.98, a P/E/G ratio of 1.31 and a beta of 0.48.
Encompass Health (NYSE:EHC) last announced its earnings results on Monday, February 26th. The company reported $0.70 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.66 by $0.04. Encompass Health had a return on equity of 20.59% and a net margin of 6.45%. The firm had revenue of $1.02 billion during the quarter, compared to analyst estimates of $1 billion. research analysts expect that Encompass Health will post 3.36 EPS for the current fiscal year.
The company also recently disclosed a quarterly dividend, which will be paid on Monday, April 16th. Stockholders of record on Monday, April 2nd will be given a dividend of $0.25 per share. The ex-dividend date of this dividend is Thursday, March 29th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 1.72%. Encompass Health’s payout ratio is 37.31%.
ILLEGAL ACTIVITY NOTICE: “Encompass Health Corp (EHC) Given $57.20 Average Price Target by Analysts” was originally posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this news story on another domain, it was stolen and republished in violation of U.S. and international copyright laws. The original version of this news story can be accessed at https://www.dispatchtribunal.com/2018/04/07/encompass-health-corp-ehc-given-57-20-average-price-target-by-analysts.html.
Encompass Health Company Profile
Encompass Health Corporation, formerly HealthSouth Corporation, is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies.
Get a free copy of the Zacks research report on Encompass Health (EHC)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.